Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration

被引:30
作者
Miyazawa, Haruna [1 ,2 ]
Honda, Tomoyuki [1 ,2 ]
Miyauchi, Sayuri [1 ,2 ]
Domon, Hisanori [1 ]
Okui, Takafumi [1 ,2 ]
Nakajima, Takako [1 ,3 ]
Tabeta, Koichi [1 ]
Yamazaki, Kazuhisa [1 ,2 ]
机构
[1] Niigata Univ, Ctr Transdisciplinary Res, Chuo Ku, Niigata 9518514, Japan
[2] Niigata Univ, Lab Periodontol & Immunol, Div Oral Sci Hlth Promot, Grad Sch Med & Dent Sci,Chuo Ku, Niigata 9518514, Japan
[3] Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Chuo Ku, Niigata 9518514, Japan
基金
日本学术振兴会;
关键词
PCSK9; LDL cholesterol; Periodontitis; Chronic inflammation; CORONARY-HEART-DISEASE; LIPOPROTEIN RECEPTOR GENE; INFLAMMATORY MARKERS; PROTEIN; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; TRANSCRIPTION; MECHANISMS; CELLS; RISK;
D O I
10.1016/j.cca.2011.09.023
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Periodontal disease increases the risk of atherothrombotic disease, and high concentrations of low density lipoprotein (LDL) cholesterol are considered to be involved: however, the underlying mechanisms are largely unknown. Recent studies demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a critical role in circulating LDL cholesterol concentrations. The aim of the present study is to analyze serum PCSK9 concentrations and their relation to lipoprotein concentrations in periodontitis patients. Methods: Sera were obtained from 40 periodontitis patients and 30 control subjects. PCSK9 concentrations, high-sensitivity C-reactive protein (hs-CRP), IL-6, TNF-alpha and Porphyromonas gingivalis antibodies were measured by ELISA, and lipid profiles were determined by a commercial laboratory. Results: Periodontitis patients demonstrated significantly higher serum antibody titer to P. gingivalis and hs-CRP concentrations than control subjects, suggesting infection with P. gingivalis and a systemic inflammatory response. PCSK9 concentrations in periodontitis patients were significantly higher than those in control subjects. However, the concentrations of total and LDL cholesterols were not significantly different between periodontitis patients and control subjects. Moreover, no correlations were observed between PCSK9 concentrations and lipid profiles. Conclusion: Periodontal infection upregulates PCSK9 production. However, further studies are required to elucidate how periodontal infection affects PCSK9 concentrations and subsequent lipid metabolism. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 159
页数:6
相关论文
共 50 条
  • [1] Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants
    Araki, Shunsuke
    Suga, Shutaro
    Miyake, Fuyu
    Ichikawa, Shun
    Kinjo, Tadamune
    Yamamoto, Yukiyo
    Kusuhara, Koichi
    EARLY HUMAN DEVELOPMENT, 2014, 90 (10) : 607 - 611
  • [2] PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
    Cariou, Bertrand
    Ding, Zufeng
    Mehta, Jawahar L.
    ATHEROSCLEROSIS, 2016, 253 : 275 - 277
  • [3] Reduction of LDL cholesterol by a monoclonal antibody to PCSK9 in rodents and nonhuman primates
    Gusarova, Viktoria
    Howard, Victor G.
    Okamoto, Haruka
    Koehler-Stec, Ellen-Marie
    Papadopoulos, Nicholas
    Murphy, Andrew J.
    Yancopoulos, George D.
    Stahl, Neil
    Sleeman, Mark W.
    CLINICAL LIPIDOLOGY, 2012, 7 (06) : 737 - 743
  • [4] Beyond LDL Cholesterol, a New Role for PCSK9
    Akram, Omar N.
    Bernier, Adeline
    Petrides, Francine
    Wong, Gida
    Lambert, Gilles
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (07) : 1279 - 1281
  • [5] Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol
    Newman, Connie B.
    Tobert, Jonathan A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04) : 784 - 790
  • [6] Antibodies to PCSK9 A Superior Way to Lower LDL Cholesterol?
    Maxwell, Kara N.
    Breslow, Jan L.
    CIRCULATION RESEARCH, 2012, 111 (03) : 274 - 277
  • [7] Plasma PCSK9 levels correlate with cholesterol in men but not in women
    Mayne, Janice
    Raymond, Angela
    Chaplin, Anna
    Cousins, Marion
    Kaefer, Nadine
    Gyamera-Acheampong, Charles
    Seldah, Nabil G.
    Mbikay, Majambu
    Chretien, Michel
    Ooi, Teik Chye
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (02) : 451 - 456
  • [8] PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
    Luquero, Aureli
    Badimon, Lina
    Borrell-Pages, Maria
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] PCSK9 INHIBITORS AS LDL CHOLESTEROL-LOWERING AGENTS: RATIONALE, CONCERNS AND PRELIMINARY OUTCOMES
    Costet, P.
    DRUGS OF THE FUTURE, 2012, 37 (05) : 331 - 341
  • [10] Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
    Schmidt, Amand F.
    Holmes, Michael V.
    Preiss, David
    Swerdlow, Daniel I.
    Denaxas, Spiros
    Fatemifar, Ghazaleh
    Faraway, Rupert
    Finan, Chris
    Valentine, Dennis
    Fairhurst-Hunter, Zammy
    Hartwig, Fernando Pires
    Horta, Bernardo Lessa
    Hypponen, Elina
    Power, Christine
    Moldovan, Max
    van Iperen, Erik
    Hovingh, Kees
    Demuth, Ilja
    Norman, Kristina
    Steinhagen-Thiessen, Elisabeth
    Demuth, Juri
    Bertram, Lars
    Lill, Christina M.
    Coassin, Stefan
    Willeit, Johann
    Kiechl, Stefan
    Willeit, Karin
    Mason, Dan
    Wright, John
    Morris, Richard
    Wanamethee, Goya
    Whincup, Peter
    Ben-Shlomo, Yoav
    McLachlan, Stela
    Price, Jackie F.
    Kivimaki, Mika
    Welch, Catherine
    Sanchez-Galvez, Adelaida
    Marques-Vidal, Pedro
    Nicolaides, Andrew
    Panayiotou, Andrie G.
    Onland-Moret, N. Charlotte
    van der Schouw, Yvonne T.
    Matullo, Giuseppe
    Fiorito, Giovanni
    Guarrera, Simonetta
    Sacerdote, Carlotta
    Wareham, Nicholas J.
    Langenberg, Claudia
    Scott, Robert A.
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (01)